From April 1, 2022 to June 30, 2022, the company has repurchased 0 shares, representing 0% for KRW 0 million. With this, the company has completed the repurchase of 246,000 shares, representing 2.46% for KRW 2,962.2 million under the buyback announced on January 17, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
13,490 KRW | +7.06% | +2.98% | -8.11% |
02-14 | HansBiomed Corporation Reports Earnings Results for the First Quarter Ended December 31, 2023 | CI |
2023 | HansBiomed Corporation(KOSDAQ:A042520) added to S&P Global BMI Index | CI |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-8.11% | 120M | |
+8.29% | 124B | |
-5.61% | 11.02B | |
+4.83% | 8.88B | |
+39.60% | 5.45B | |
-22.04% | 4.74B | |
+8.39% | 3.44B | |
-6.28% | 2.84B | |
-10.23% | 2.15B | |
-5.99% | 2.11B |
- Stock Market
- Equities
- A042520 Stock
- News HansBiomed Corporation
- Tranche Update on HansBiomed Corporation's Equity Buyback Plan announced on January 17, 2022.